UNSPSC 51113500: Alkylating agent piperazines

This classification denotes six-membered ring with two nitrogen atoms positioned opposite to one another, substances called piperazines, that constitute reactive chemicals that introduce into biologically active molecules alkyl radicals and thereby disrupt functioning of the same, substances called alkyl-ating agents, thus the term ALKYLATING AGENT PIPERAZINES.

UNSPSC 51113500 Alkylating agent piperazines is a Class code that encompasses pharmaceutical products used in therapeutic contexts, though recent state and local procurement activity under this code appears limited. The Texas Health and Human Services Commission issued a Request for Information (RFI) in April 2026 seeking vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, which signals state interest in direct pharmaceutical sourcing models and cost management strategies. State health and human services agencies represent the primary issuing bodies for this commodity code, as pharmacy benefit management and prescription fulfillment fall within their procurement mandate for employee health plans and Medicaid or state-administered programs.

The RFI activity is concentrated in Texas, with no additional recent opportunities in the source supporting broader geographic spread across other states or jurisdictions. The Texas HHS Commission RFI, posted April 3, 2026, with the same-day response deadline, sought vendor experience in direct contracting with self-insured employers and government health plans, capability to negotiate net pricing models outside traditional pharmacy benefit manager and group purchasing organization channels, and capacity to implement outcomes-based agreements. The exploratory nature of this RFI indicates the state is gathering market intelligence before issuing a formal RFP; no award value, budget allocation, or implementation timeline has been specified at this stage.